The Secondary Pulmonary Hypertension Diagnosis is Not Useful in Lung Allocation (opens in a new tab)
Transplant Proc
Primary practice
Columbia University Irving Medical Center
New York, New York
Find Dr. Grewal's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Grewal practices at Columbia University Irving Medical Center in New York, New York.
Dr. Grewal's NPI, 1114215126, was assigned on July 12, 2011. Dr. Grewal graduated from Ross University School of Medicine in 2011. Dr. Grewal holds New York license 276791.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Grewal's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Grewal's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Grewal is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Grewal to 1 more medical group, named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Grewal practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Columbia University Irving Medical Center | Available with a free account |
| +1 more site and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Pulmonary disease is Dr. Grewal's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Grewal is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Grewal's licenses on file in 3 states: New York, Ohio and New Jersey.
Dmand AI lists chronic lung disease, pneumonia, pneumonia and respiratory infection, pulmonary fibrosis, pulmonary heart disease and tobacco use among the conditions Dr. Grewal treats.
Counts of pulmonologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
CMS data shows 731 Medicare services from Dr. Grewal across 7 procedure codes in 2024, for 136 Medicare patients. Medicare paid $98,914 for them.
Medians across 1,044 pulmonologists in New York with Dmand AI profiles that report each measure.
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Grewal?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Grewal and other pulmonologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
CMS counts 136 Medicare patients who saw Dr. Grewal in 2024. The largest group is 65 to 74, with 86 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 3.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Grewal's median patient age at 67, with 42% women.
Share of Medicare patients with each condition. A patient can have several.
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Median age 67
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
In 2024, Dr. Grewal wrote 49 Medicare Part D claims for 17 patients. 86% of them were for generic drugs. CMS names the drug for 20 of them, across 1 drug with 11 or more claims each, at $917 in total drug cost. In 2023, CMS named 12 claims across 1 drug.
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Drugs named by CMS: 1 in 2024, 1 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Grewal for performance year 2024, reported through an alternative payment model (APM). Dr. Grewal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Grewal as offering telehealth.
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dmand AI links 21 papers to Dr. Grewal, published from 2017 to 2024. 2020 was the busiest year, with 3. The most frequent topics are Lung Transplantation, Tissue and Organ Procurement and Lung. Dr. Grewal has published most often in J Heart Lung Transplant. Dr. Grewal's most frequent co-authors are Harpreet Singh Grewal, MD, Selim Mehmet Arcasoy, MD and Luke John Benvenuto, MD.
Topics Dr. Grewal writes about most
Transplant Proc
J Heart Lung Transplant
Transplant Proc
See who Dr. Grewal researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Grewal works with, so you can find a warm path to the right pulmonologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
CMS Open Payments shows 15 general payments to Dr. Grewal from 11 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 100% of the total. Corcept Therapeutics paid the most, $125.
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Grewal graduated from Ross University School of Medicine in 2011.
Source: Dmand AI Professional Profile Data
Dr. Grewal is in network with 13 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.
Source: Dmand AI Insurance Network Data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
Dr. Harpreet Singh Grewal's NPI number is 1114215126. It was assigned on July 12, 2011, and it is active in the NPI Registry.
Dr. Harpreet Singh Grewal is a pulmonologist in New York, New York. The primary specialty in the NPI Registry is Pulmonary Disease Physician (taxonomy code 207RP1001X).
Dr. Grewal practices at 622 W 168th St, New York, NY 10032. Dr. Grewal's primary practice is Columbia University Irving Medical Center in New York, New York. Dmand AI also links Dr. Grewal to 1 medical group.
The practice phone on file for Dr. Grewal is (212) 297-4255.
Dr. Grewal holds New York license 276791, one of the licenses on file in 3 states.
Dmand AI has state licenses on file for Dr. Grewal in New York (2014 to 2026), Ohio (2011 to 2027) and New Jersey (2018 to 2025).
Dr. Grewal is affiliated with NewYork-Presbyterian/Weill Cornell Medical Center.
Dr. Grewal is linked to ColumbiaDoctors. Dmand AI links Dr. Grewal to 1 more medical group.
Yes. CMS data shows Dr. Grewal billed Medicare for 731 services in 2024, and Dr. Grewal accepts Medicare assignment.
Yes. The CMS Doctors and Clinicians file lists Dr. Grewal as offering telehealth services.
Dr. Grewal's MIPS final score for performance year 2024 is 100 out of 100, reported through an alternative payment model (APM).
CMS counts 136 Medicare patients who saw Dr. Grewal in 2024, with an average age of 66.
Yes. Dr. Grewal is board certified in critical care medicine by the American Board of Internal Medicine.
In 2024, Dr. Grewal's most billed Medicare services were hospital inpatient care (99233), office visit, established patient (99215) and critical care (99291).
Dr. Grewal graduated from Ross University School of Medicine in 2011.
In 2024 Medicare Part D data, Dr. Grewal's most prescribed drugs by claims were Ceftriaxone.
CMS Open Payments shows $349 in general payments to Dr. Grewal from 11 companies from 2018 to 2024. The largest total came from Corcept Therapeutics.
Dr. Grewal graduated from medical school in 2011, 15 years ago.
Dmand AI links 21 publications to Dr. Grewal, published from 2017 to 2024.
Dr. Grewal's most frequent co-authors are Harpreet Singh Grewal, MD (16 shared papers), Selim Mehmet Arcasoy, MD (8 shared papers) and Luke John Benvenuto, MD (6 shared papers).
Dr. Grewal is in network with 13 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.
Selling to pulmonary disease practices?
See pulmonologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.